{
  "study_metadata": {
    "design": "RCT",
    "species": "Homo sapiens",
    "n_total": 48,
    "country": "Iran",
    "setting": "outpatient",
    "population": "type 2 diabetes patients",
    "inclusion_key": "T2D patients on diet/hypoglycemic agents, no antioxidant supplements",
    "exclusion_key": "type 1 diabetes, pregnant, lactating, severe heart disease, hepatic disease, renal impairment, weight loss program",
    "mean_age": null,
    "female_pct": null,
    "diabetes_status": "T2D",
    "primary_outcome": "other"
  },
  "intervention": {
    "agent": "resveratrol",
    "form": "capsule",
    "dose_mg_per_day": 800,
    "duration_weeks": 8,
    "cointerventions": "continued antidiabetic medications"
  },
  "comparison": {
    "type": "placebo",
    "description": "placebo capsules identical appearance"
  },
  "arms": [
    {
      "name": "resveratrol",
      "n": 24,
      "dose_mg_per_day": 800,
      "duration_weeks": 8
    },
    {
      "name": "placebo",
      "n": 24,
      "dose_mg_per_day": 0,
      "duration_weeks": 8
    }
  ],
  "outcomes_raw": [],
  "effects_by_outcome": [],
  "risk_of_bias": {
    "randomization_process": null,
    "deviations_from_intended": null,
    "missing_outcome_data": null,
    "measurement_of_outcome": null,
    "selection_of_reported_result": null,
    "overall": null
  },
  "effect": null,
  "where_found": [
    {
      "section": "abstract",
      "page": null
    },
    {
      "section": "methods",
      "page": null
    },
    {
      "section": "results",
      "page": null
    }
  ],
  "evidence": [
    {
      "section": "abstract",
      "page": null,
      "snippet": "Resveratrol had no significant effects on the metabolic and anthropometric parameters except for a significant reduction in weight, BMI, and blood pressure levels."
    },
    {
      "section": "methods",
      "page": null,
      "snippet": "Secondary outcomes were defined by the differences in changes of the laboratory parameters including fasting blood sugar (FBS), glycated hemoglobin (HbA1c), insulin, homeostasis model assessment of insulin resistance (HOMA-IR) ..."
    }
  ],
  "missing_fields": [
    "study_metadata.mean_age",
    "study_metadata.female_pct",
    "study_metadata.primary_outcome",
    "outcomes_raw",
    "effects_by_outcome",
    "risk_of_bias.randomization_process",
    "risk_of_bias.deviations_from_intended",
    "risk_of_bias.missing_outcome_data",
    "risk_of_bias.measurement_of_outcome",
    "risk_of_bias.selection_of_reported_result",
    "risk_of_bias.overall",
    "effect",
    "where_found.page"
  ],
  "confidence": 0.6,
  "comment": "Limited glycemic data; no effect reported.",
  "comment_detailed": "I searched the abstract, methods, and results sections for glycemic outcomes (FBS, HbA1c, insulin, HOMA-IR). The study reports no significant changes in these parameters, but numeric values and effect sizes are not provided. Consequently, outcome data and effect estimates are unknown. Additional information such as tables or full PDF would be needed to extract precise effect sizes."
}